The VLA1553 vaccine candidate for chikungunya disease was generally well tolerated and produced an immune response in 99% (263/266) of participants, according to a phase 3 randomized controlled trial published in The Lancet.
Jun 12, 2023
0
40
Animal studies indicate that a new COVID-19 vaccine developed at Rutgers may provide more durable protection against SARS-CoV-2 and its emerging variants than existing vaccines.
May 8, 2023
0
18
A mysterious illness causing fevers and headaches and leading to rapid development of acute encephalitis (within a couple of weeks of symptom onset), caused an outbreak of nearly 300 reported cases and over 100 fatalities ...
Apr 20, 2023
0
7
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune ...
Mar 6, 2023
0
98
It has been more than 100 years since the first and only tuberculosis (TB) vaccine—the Bacillus Calmette–Guérin (BCG) vaccine—was used for the first time medically in 1921. With an estimated 1.6 million people dying ...
Feb 15, 2023
1
25
Contrary to the widely shared popular belief, the primary purpose of current vaccines against COVID-19 is solely to protect against serious forms of the disease in order to prevent the risk of hospitalizations and death… ...
Feb 14, 2023
0
2
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
Uganda on Thursday received its first shipment of trial vaccines against a strain of Ebola that has claimed dozens of lives, amid cautious optimism the outbreak could soon be over.
Dec 8, 2022
0
6
In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate ...
Dec 1, 2022
0
31
Moderna announced Monday that its updated booster shot triggers strong antibody responses against three omicron subvariants.
Nov 15, 2022
0
4
